| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.17 | 8e-07 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.26 | 2e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.2 | 6e-06 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.13 | 8e-05 |